Fulcrum Therapeutics (FULC) Financials

$3.78

$-0.01 (-0.26%)

As on 15-Sep-2026 16:00EDT

Market cap

$290 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	80.00	2.81	6.34	19.16
Cost of Revenue	14.55	1.39	63.39	71.80	76.78	2.52
Gross Profit	-14.55	-1.39	16.61	-69.00	-70.44	19.16
Operating Expenses	72.09	83.38	38.51	41.67	42.12	100.22
Operating Profit (EBIT)	-86.64	-84.77	-21.90	-110.66	-112.56	-81.05
Other Income	--	--	--	--	--	--
Profit before Tax	-85.00	-74.88	-9.73	-97.34	-109.87	-80.85
Provision for Tax	--	--	--	2.00	-4.25	-2.52
Profit after Tax (Net Income)	-85.00	-74.88	-9.73	-97.34	-109.87	-78.33
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-109.87	-80.85

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	310.70	349.00	243.03	235.19	198.94	211.54
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.96	4.24	6.64	8.83	11.02	4.26
Current Liabilities	10.30	13.05	11.04	13.68	16.73	19.20
Total Liabilities	334.25	366.28	260.72	257.69	226.69	235.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	1.10	8.80	10.80	15.50	19.17	9.00
Current Assets	322.85	357.48	249.92	242.20	207.52	226.00
Total Assets	334.25	366.28	260.72	257.69	226.69	235.00
Total Debt*	5.28	6.44	8.63	10.82	13.42	0.47
Net Current Assets	312.55	344.43	238.88	228.52	190.79	206.80

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-60.07	-2.22	-90.97	-97.05	-78.48
Cash Flow from Investing Activities	--	30.72	32.23	-36.69	12.41	-129.67
Cash from Financing Activities	--	168.67	2.75	118.12	84.32	186.51
Net Cash Inflow / Outflow	--	--	--	--	-0.31	-21.64

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.23	-1.18	-0.18	-1.57	-2.11	-1.93
Cash EPS ($)	--	-1.16	-0.15	-1.54	-2.06	-1.87
Adjusted Book Value ($)	--	5.51	4.50	3.80	3.82	5.21
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.95	-0.04	-1.47	-1.86	-1.93
Free Cash Flow per Share ($)	--	-0.95	-0.05	-1.48	-1.90	-1.98

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-24.67	-3.91	-42.47	-51.78	-51.00
ROE (%)	-25.77	-25.30	-4.07	-44.84	-53.53	-51.08
ROA (%)	-29.72	-23.89	-3.75	-40.19	-47.60	-42.97
EBIT Margin (%)	--	--	-24.79	-3,470.05	-1,768.12	-422.97
Net Margin (%)	--	--	-12.16	-3,470.05	-1,732.43	-408.77
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-1.00	27.52	-0.56	-0.67	1.17
EBIT Growth (%)	-5.56	-277.53	79.62	13.20	-38.34	-13.19
Net Profit Growth (%)	-16.10	-669.97	90.01	11.41	-40.26	-14.45
EPS Growth (%)	-0.93	-5.56	0.89	0.25	-0.09	0.22
Book Value Growth (%)	18.86	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-9.57	-26.08	-4.29	-3.45	-9.16
Price / Book Value	0.93	2.05	1.04	1.78	1.91	3.39
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.09	-5.04	-1.16	-2.02	-1.73	-6.37
Close Price ($)	3.66	11.31	4.70	6.75	7.28	17.69
High Price ($)	15.74	15.74	13.70	15.00	24.79	33.10
Low Price ($)	2.91	2.32	2.86	2.25	3.21	6.85
Market Cap ($ Cr)	289.93	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.02	0.04	0.05	0.07	0.00
Short term debt to equity ratio	0.01	0.01	0.01	0.01	0.01	0.05
Current Ratio	31.35	27.40	22.63	17.71	12.41	11.77
Quick Ratio	31.35	--	--	--	12.44	11.80
Interest Coverage	--	--	--	--	-41.69	-29.78

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	4.18	80.18	17.05	21.45
Asset Turnover	--	--	0.31	0.01	0.03	0.11
Receivable days	--	--	12.76	216.81	149.48	64.97
Inventory Days	--	--	--	-2.41	-2.25	-236.29
Payable days	--	362.10	11.30	16.27	20.04	643.87
Cash Conversion Cycle	--	--	--	198.13	127.19	-815.19

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.